Yesterday, 10x Genomics revealed the first 45 members chosen to participate in its Visium Clinical Translational Research Network (CTRN).
The 10x Visium CTRN was established to improve and accelerate workflows related to spatial cellular relationship in clinical translational research studies. The members that were selected are focused on research in oncology, immuno-oncology, neuroscience, infectious disease, inflammation and fibrosis, COVID-19 and more.
Michael Schnall-Levin, Senior Vice President of R&D and founding scientist at 10x Genomics said: “the technologies powering today’s research have led to discoveries that would have been unprecedented ten years ago, but the tools that help translate genomic research to a clinical setting haven’t always kept pace”. He goes on to elaborate that, “by establishing the Virisum Clinical Translational Research Network, we can help accelerate the clinical translational process by bridging the gap between scientific discoveries and patient care solutions”.
The first 45 members of the Visium CTRN were selected from 185 applications and represent a diverse range of studies worldwide. The CRTN will connect researchers from 39 global institutions including:
- Barcelona Supercomputing Center
- Cancer Research Centre of Lyon (CRCL)
- Centre de Recherche des Cordeliers (Inserm, Sorbonne Université, Université de Paris)
- Duke University
- Garvan Institute of Medical Research
- Hospital Italiano Buenos Aires, IMTIB
- Humanitas Research Hospital
- Institut Imagine
- Johns Hopkins Medical Institutions
- Josep Carreras Leukaemia Research Institute
- Lieber Institute for Brain Development
- Ludwig-Maximilians University Munich
- Mass General Cancer Center
- Nanjing Drum Tower Hospital
- Queensland University of Technology
- RIKEN Center for Biosystems Dynamics Research
- RIKEN Center for Integrative Medical Sciences
- Sylvester Comprehensive Cancer Center and Bascom Palmer Eye Institute, University of Miami Miller School of Medicine
- University of Michigan Rogel Cancer Center
Members of the Visium CTRN will gain exclusive access to a collaborative, global research community that is dedicated to accelerating clinical translational research workflows. Members will also receive substantial discounts and support relating to the 10x Visium platform, as well as having the opportunity to present at the 10x Genomics CTRN Spatial summit, the details of which will be revealed later this year.